- Home
- SSL vs BPMC Comparison
SSL vs BPMC Comparison
Compare SSL & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSL
- BPMC
- Stock Information
- Founded
- SSL 1950
- BPMC 2008
- Country
- SSL South Africa
- BPMC United States
- Employees
- SSL N/A
- BPMC N/A
- Industry
- SSL Oil & Gas Production
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- SSL Energy
- BPMC Health Care
- Exchange
- SSL Nasdaq
- BPMC Nasdaq
- Market Cap
- SSL 4.6B
- BPMC 5.2B
- IPO Year
- SSL N/A
- BPMC 2015
- Fundamental
- Price
- SSL $5.20
- BPMC $96.93
- Analyst Decision
- SSL
- BPMC Buy
- Analyst Count
- SSL 0
- BPMC 19
- Target Price
- SSL N/A
- BPMC $120.79
- AVG Volume (30 Days)
- SSL 1.1M
- BPMC 700.7K
- Earning Date
- SSL 01-01-0001
- BPMC 10-30-2024
- Dividend Yield
- SSL 12.10%
- BPMC N/A
- EPS Growth
- SSL N/A
- BPMC N/A
- EPS
- SSL N/A
- BPMC N/A
- Revenue
- SSL $15,070,363,793.00
- BPMC $434,415,000.00
- Revenue This Year
- SSL N/A
- BPMC $108.13
- Revenue Next Year
- SSL $5.64
- BPMC $38.91
- P/E Ratio
- SSL N/A
- BPMC N/A
- Revenue Growth
- SSL N/A
- BPMC 100.93
- 52 Week Low
- SSL $5.14
- BPMC $62.56
- 52 Week High
- SSL $12.58
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- SSL 30.15
- BPMC 60.32
- Support Level
- SSL $5.30
- BPMC $96.52
- Resistance Level
- SSL $5.45
- BPMC $103.55
- Average True Range (ATR)
- SSL 0.12
- BPMC 3.65
- MACD
- SSL -0.03
- BPMC 1.09
- Stochastic Oscillator
- SSL 4.13
- BPMC 70.84
About SSL Sasol Ltd.
Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main segments: Energy business and Chemical business. It generates maximum revenue from the Chemicals segment. The company operates coal mines and its upstream interests in oil and gas, both of which are used as feedstock in the company's energy and chemicals operations. Sasol markets commodity and performance chemicals, sells liquid fuel products, and markets, distributes and transports pipeline gas. Geographically the company generates the majority of its revenue from South Africa.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.